HK4288A - Sustained release theophylline tablet having reduced bulk - Google Patents

Sustained release theophylline tablet having reduced bulk

Info

Publication number
HK4288A
HK4288A HK42/88A HK4288A HK4288A HK 4288 A HK4288 A HK 4288A HK 42/88 A HK42/88 A HK 42/88A HK 4288 A HK4288 A HK 4288A HK 4288 A HK4288 A HK 4288A
Authority
HK
Hong Kong
Prior art keywords
sustained release
reduced bulk
release theophylline
theophylline tablet
theophylline
Prior art date
Application number
HK42/88A
Other languages
English (en)
Inventor
T. David Stephen
Brooks Dana
E. Gallian Claude
Original Assignee
Bristol-Myers Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol-Myers Company filed Critical Bristol-Myers Company
Publication of HK4288A publication Critical patent/HK4288A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK42/88A 1980-05-06 1988-01-21 Sustained release theophylline tablet having reduced bulk HK4288A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14742980A 1980-05-06 1980-05-06
US24978781A 1981-04-01 1981-04-01

Publications (1)

Publication Number Publication Date
HK4288A true HK4288A (en) 1988-01-29

Family

ID=26844921

Family Applications (1)

Application Number Title Priority Date Filing Date
HK42/88A HK4288A (en) 1980-05-06 1988-01-21 Sustained release theophylline tablet having reduced bulk

Country Status (17)

Country Link
AT (1) AT380789B (enrdf_load_stackoverflow)
AU (1) AU549299B2 (enrdf_load_stackoverflow)
CA (1) CA1165241A (enrdf_load_stackoverflow)
CY (1) CY1368A (enrdf_load_stackoverflow)
DE (1) DE3117756A1 (enrdf_load_stackoverflow)
DK (1) DK155976C (enrdf_load_stackoverflow)
FI (1) FI811356A7 (enrdf_load_stackoverflow)
FR (1) FR2484253A1 (enrdf_load_stackoverflow)
GB (1) GB2078518B (enrdf_load_stackoverflow)
HK (1) HK4288A (enrdf_load_stackoverflow)
IE (1) IE51157B1 (enrdf_load_stackoverflow)
IT (1) IT1209867B (enrdf_load_stackoverflow)
KE (1) KE3722A (enrdf_load_stackoverflow)
LU (1) LU83342A1 (enrdf_load_stackoverflow)
NL (1) NL8102168A (enrdf_load_stackoverflow)
SE (1) SE452550B (enrdf_load_stackoverflow)
SG (1) SG30987G (enrdf_load_stackoverflow)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4547358A (en) * 1980-05-06 1985-10-15 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
US4503031A (en) * 1982-12-17 1985-03-05 Glassman Jacob A Super-fast-starting-sustained release tablet
HU187215B (en) * 1983-01-26 1985-11-28 Egyt Gyogyszervegyeszeti Gyar Method for producing pharmaceutical product of high actor content and prolonged effect
US4753945A (en) * 1986-02-19 1988-06-28 Eye Research Institute Of Retina Foundation Stimulation of tear secretion with phosphodiesterase inhibitors
FR2595945B1 (fr) * 1986-03-19 1990-01-19 Doms Laboratoires Comprime-retard de theophylline a base de p.v.c., et son procede de preparation
USD557612S1 (en) * 2006-04-10 2007-12-18 Parfums Christian Dior Flask for a cosmetic product

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE636568A (enrdf_load_stackoverflow) * 1961-01-31
DE1228029C2 (de) * 1964-05-09 1973-05-17 Merck Ag E Verfahren zur Herstellung von Tabletten durch Pressen von Pulvergemischen ohne vorhergehende Granulation
US3723614A (en) * 1971-01-06 1973-03-27 Ciba Geigy Ag Maltese-cross scored tablet
US4264573A (en) * 1979-05-21 1981-04-28 Rowell Laboratories, Inc. Pharmaceutical formulation for slow release via controlled surface erosion

Also Published As

Publication number Publication date
SE8102814L (sv) 1981-11-07
DK200181A (da) 1981-11-07
FI811356L (fi) 1981-11-07
NL8102168A (nl) 1981-12-01
SE452550B (sv) 1987-12-07
DE3117756A1 (de) 1982-04-29
DK155976B (da) 1989-06-12
KE3722A (en) 1987-04-30
LU83342A1 (fr) 1982-01-20
DK155976C (da) 1989-10-30
SG30987G (en) 1987-07-17
IE51157B1 (en) 1986-10-15
GB2078518A (en) 1982-01-13
FR2484253B1 (enrdf_load_stackoverflow) 1983-06-03
CA1165241A (en) 1984-04-10
GB2078518B (en) 1984-04-11
FR2484253A1 (fr) 1981-12-18
AU7020581A (en) 1981-11-12
FI811356A7 (fi) 1981-11-07
IT8148406A0 (it) 1981-05-06
IE810989L (en) 1981-11-06
CY1368A (en) 1987-08-07
AT380789B (de) 1986-07-10
AU549299B2 (en) 1986-01-23
ATA202081A (de) 1985-12-15
IT1209867B (it) 1989-08-30
DE3117756C2 (enrdf_load_stackoverflow) 1992-11-26

Similar Documents

Publication Publication Date Title
IT1138450B (it) Derivati dell'acido 2-idrossi-5-fenilazobenzoico,composizioni farmaceutiche che li contengono e procedimento per la loro preparazione
JPS649930A (en) Device for drug control release
IT8123026A0 (it) Derivati dell'idantoina, procedimento per la loro preparazione, e medicinali contenenti gli stessi.
IT1096813B (it) Derivati dell'acido 1,2,3-tiadiazol-5-carbossilico,mezzi ad azione erbicida e regolatrice della crescita contenenti questi composti e procedimento per prepararli
FI872577A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten, hydrofobisen tai niukkaliukoisen aineen mikronisoitujen, hydrofilisoitujen hiukkasten valmistamiseksi
DE3274064D1 (en) Stabilized insulin preparations and method for their production
GB8719877D0 (en) Antiviral compounds
IL55236A (en) Prostaglandin i2 derivatives,process for their production and pharmaceutical compositions containing them
IT1195297B (it) Composti xantati antivirali,procedimento per la loro produzione e composizioni farmaceutiche che li contengono
HK4288A (en) Sustained release theophylline tablet having reduced bulk
JPS5572117A (en) Analgesic tablet and its manufacture
BE890808A (fr) Nouvelle forme galenique d'administration de metoclopramide, son procede de preparation et medicament comprenant cette nouvelle forme
FR2315267A1 (fr) Nouvelle 1,9-lactone du type prostaglandine, son procede de preparation et medicament la contenant
IT8019992A0 (it) Derivati dell'acido 3-fosfonocefalosporanico, procedimenti per la loro preparazione e composizione farmaceutica che li comprende.
IT1151093B (it) Preparato medicinale ad azione citostatica,nonche' derivati dell'acido iso anurico e procedimento per la loro preparazione
IT1209896B (it) Antibiotico bmg162-af2 procedimento per la sua produzione e medicinale antitumorale contenente il suddetto antibiotico come ingrediente attivo
BE891557A (fr) Procede de preparation de comprimes analgesiques, directement compressibles, d'acetaminophene renfermant de la carboxyme-thylcellulose sodique et nouveaux produits ainsi obtenus
JPS552601A (en) Anti-tumor agent for non-injection use
FR2339397A1 (fr) Nouveaux ethers d'oximes, procede de preparation de ceux-ci et medicaments les contenant
IT8122890A0 (it) Derivati dell'acido 2,4-esadienoico utili come erbicidi e fitoregolatori.
FR2684988B1 (fr) Procede industriel de synthese de l'acide hydroxy-10-decene-e-ouique et de l'acide oxo-9-decene-2-ouique, principe actifs de la gelee royale.
IE782540L (en) Tablets containing¹1,3-bis(2-carboxychromon-5-yloxy)-2-hydroxypropane
IL55688A (en) 1,4-dihydropyridazine-5-carboxylic acid derivatives,their production and pharmaceutical compositions containing them
IT1150687B (it) Derivati dell'acido d-2-(6-metossi-2-naftil) propionico ad attivita' terapeutica,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
FR2522966B1 (fr) Comprime en forme de gelule, procede et dispositif pour sa preparation

Legal Events

Date Code Title Description
PE Patent expired